🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Safety and Tolerability in Healthy Volunteers

A Clinical Study of HRS-7156 in Healthy Participants NCT07601087Phase 11 site📍 Shanghai Shandong Suncadia Medicine Co., Ltd. · Tests: HRS-7156, HRS-7156 placebo Safety and Pharmacokinetics of ALZ-507 in Healthy Elderly Adults NCT07824271Phase 11 site📍 Miami Alzheon Inc. · Tests: ALZ-507, Placebo A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease. NCT06466525Phase 13 sites📍 Melbourne📍 Melbourne📍 Melbourne Longevity Biotech Australia Pty Ltd (subsidiary) · Tests: LBT-3627, Placebo A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes NCT06945406Phase 11 site📍 Neuss Eli Lilly and Company · Tests: LY4057996 SC, LY4057996 IV, Placebo SC, Placebo IV, Degludec SC Safety and Tolerability of an Ultra Absorbency Menstrual Tampon Compared to a Commercially Marketed Tampon NCT07807891NA1 site📍 St. Petersburg Lyv Life Inc. (dba: Cora) · Tests: Tampon A First-in-Human Single and Multiple Ascending Dose Study of MT-201 NCT07219368Phase 11 site📍 San Diego Mirador Therapeutics, Inc. · Tests: MT-201, Placebo A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) NCT06657768Phase 113 sites📍 Los Alamitos📍 Lady Lake📍 Maitland Eli Lilly and Company · Tests: LY4006895, Placebo A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function NCT07315360Phase 14 sites📍 Lake Forest📍 Orlando📍 Tampa Pfizer · Tests: PF-07328948 A Phase 1 Study of CLYM116 in Normal Healthy Volunteers NCT07248865Phase 11 site📍 Brisbane Climb Bio, Inc. · Tests: CLYM116, Placebo SAR447971 First-in-human Study NCT07629336Phase 11 site📍 Leiden Sanofi · Tests: SAR447971, Placebo A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults NCT07013097Phase 11 site📍 Beijing Prime Gene Therapeutics Co., Ltd. · Tests: PG-033, PG-033 placebo comparator A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) NCT06649110Phase 1, Phase 287 sites📍 Scottsdale📍 Orange📍 Stanford Novartis Pharmaceuticals · Tests: LTP, Placebo A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients NCT06249919Phase 1, Phase 216 sites📍 Bucheon-si📍 Gwangju📍 Ilsan Neuracle Science Co., LTD. · Tests: NS101, Placebo A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity. NCT07511205Phase 13 sites📍 Glendale📍 Brooklyn📍 Harrow AstraZeneca · Tests: AZD1043, Placebo A Clinical Study of SPH7854 Granules in Healthy Subjects. NCT06483373EARLY Phase 11 site📍 Chengdu Shanghai Pharmaceuticals Holding Co., Ltd · Tests: SPH7854, Placebo A Study to Evaluate MWN109 Injection in Healthy Subjects NCT06859853Phase 11 site📍 Melbourne Shanghai Minwei Biotechnology Co., Ltd · Tests: Placebo, Subcutaneous single and mutiple dose A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants NCT06682975Phase 11 site📍 Leiden Zealand Pharma · Tests: ZP9830, Placebo A Single Ascending Dose Study of DTI-117 Given Intramuscularly in Healthy Participants. NCT07882472Phase 11 site📍 Austin Dignify Therapeutics · Tests: DTI-117, Placebo A Study to Evaluate the Safety, Tolerability and PK of SK-08 NCT07021157Phase 11 site📍 Hangzhou Consun Pharmaceutical Group · Tests: SK-08, Placebo Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance NCT06894875NA1 site📍 Melbourne Nuritas Ltd · Tests: Lentil protein hydrolysate, Placebo MCC micro-crystalline cellulose A Study Testing the Safety and Effects of FB102 in Healthy Volunteers NCT07623057Phase 12 sites📍 Eastwood📍 Maroochydore Forte Biosciences, Inc. · Tests: FB102 Single dose - Part A, FB102 Multiple doses - Part B, FB102 Placebo, FB102 Multiple doses - Part C A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade NCT07459166Phase 21 site📍 Glendale Clear Scientific, Inc. · Tests: Naloxone Hydrochloride, Fentanyl, Sterile Saline, CS-1103 A Study to Evaluate HB0034 in Healthy Chinese Adult Participants NCT06716151Phase 11 site📍 Jinan Shanghai Huaota Biopharmaceutical Co., Ltd. · Tests: HB0034, HB0034 matching placebo A Single and Multiple Ascending Dose Escalation and Food Effect Study of QX-4533 in Healthy Participants NCT07678463Phase 11 site📍 Brisbane QuantX Biosciences, Inc. · Tests: QX-4533, Placebo A Study of IBI3032 in Healthy Participants NCT07120425Phase 11 site📍 Lenexa Fortvita Biologics (USA)Inc. · Tests: IBI3032, placebo Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers NCT06995482Phase 12 sites📍 Miami Lakes📍 Pune Kashiv BioSciences, LLC · Tests: KSHN001034, KSHN001034, KSHN001034, KSHN001034, KSHN001034 A Phase Ia Clinical Trial of HW241045 NCT07448194Phase 11 site📍 Beijing Hubei Bio-Pharmaceutical Industrial Technological Institute… · Tests: HW241045, Placebo Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali. NCT07758985Phase 11 site📍 Bamako Medicines for Malaria Venture · Tests: Cohort 1 low dose lotilaner with a high-fat meal, Cohort 1 low dose placebo with a high-fat meal, Cohort 2 high dose lo… A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD) NCT07239947Phase 110 sites📍 Hefei📍 Wuhu📍 Beijing Bambusa Therapeutics · Tests: BBT001, Placebo Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. NCT07377175Phase 11 site📍 Hangzhou China National Biotec Group Company Limited · Tests: BSY001 for Injection (37.5mg), BSY001 for Injection (75 mg), BSY001 for Injection (150 mg), BSY001 for Injection (200 m…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy